← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2006Last known activity
Jan 31, 2025
Timeline
2000s
- Jan 1, 2004
ERYtech Pharma— Founded
Drugs by trial phase (13 distinct, 13 trials)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (14)
- NCT06605651Lead sponsorPhase 2Jan 31, 2025
- NCT06605651OfficialPhase 2Jan 31, 2025
- NCT04292743CollaboratorPhase 1May 31, 2020
- NCT03674242Lead sponsorPhase 2/Phase 3Dec 31, 2018
- NCT03665441Lead sponsorPhase 3Sep 30, 2018
- NCT03267030CollaboratorPhase 2Aug 23, 2017
- NCT02195180Lead sponsorPhase 2Jul 1, 2014
- NCT01910428Lead sponsorPhase 1Oct 1, 2013
- NCT02197650Lead sponsorN/AFeb 1, 2013
- NCT01810705Lead sponsorPhase 2Feb 1, 2013
- NCT01518517Lead sponsorPhase 2/Phase 3Dec 1, 2009
- NCT01523808Lead sponsorPhase 1Jun 1, 2009
- NCT01523782Lead sponsorPhase 2Apr 1, 2009
- NCT00723346Lead sponsorPhase 1/Phase 2Jan 1, 2006
Details
- Founded
- Lyon, FR Jan 1, 2004
- Last known activity
- Jan 31, 2025